Vilnius, Lithuania

Mantas Ziaunys

This inventor holds 1 USPTO granted patent. Top assignee: Vilnius University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mantas Ziaunys. Retrieved from https://idiyas.com/inventor/mantas-ziaunys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mantas Ziaunys: Innovator in Protein Aggregation Inhibition

Introduction

Mantas Ziaunys is a notable inventor based in Vilnius, Lithuania. He has made significant contributions to the field of biochemistry, particularly in the area of protein aggregation. His innovative work has the potential to impact various medical applications.

Latest Patents

Mantas Ziaunys holds a patent for the invention titled "Inhibition of protein amyloid aggregation using fluorinated benzenesulfonamides." This invention teaches a class of fluorinated benzenesulfonamides of general structure I, which is crucial for understanding how to inhibit protein aggregation.

Career Highlights

Ziaunys is affiliated with Vilnius University, where he engages in research and development. His work at the university allows him to explore new frontiers in biochemistry and collaborate with other experts in the field.

Collaborations

Mantas Ziaunys has worked alongside notable colleagues such as Daumantas Matulis and Andrius Sakalauskas. Their combined expertise enhances the research output and innovation potential within their projects.

Conclusion

Mantas Ziaunys is a prominent figure in the realm of protein aggregation research, with a patent that showcases his innovative approach. His contributions at Vilnius University and collaborations with esteemed colleagues further solidify his impact in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…